For the first time, unleashing the power of antimicrobial peptides

Peptides can now be used in medical devices to kill bacteria. Mimicking our own immune system, it is non toxic and safe.

How it works

Amferia wound dressing launched in eight European countries by Orkla

See where you can buy it >

How this platform technology
can revolutionise treatments

Amferia’s general patent now granted in Europe, the U.S. and China

Amferia’s innovation is protected by three strong patent families. The basic patent is already in force in Europe, the U.S. and China, and pending in several other countries. Ongoing R&D continues to generate new patent applications.

Read about all our patents >

Launching our first product for veterinary use

Addressing antibiotic resistance the sustainable way

Read about the global threat and Amferia's vision >

After years of research, we suddenly realised how to combine our findings.
It was a eureka moment.

Read about the Amferia story >

New Study finds Amferia's Peptide-Hydrogel restores the effectiveness of antibiotics against drug-resistant bacteria

The latest news from Amferia >

For the first time, unleashing the power of antimicrobial peptides

Amferia wound dressing launched in eight European countries by Orkla

How this platform technology
can revolutionise treatments

Wound Care

Pre-surgery

Antimicrobial sprays

Antibacterial coatings

Amferia’s general patent now granted in Europe, the U.S. and China

Launching our first product for veterinary use

Addressing antibiotic resistance the sustainable way

After years of research, we suddenly realised how to combine our findings.
It was a eureka moment.

New Study finds Amferia's Peptide-Hydrogel restores the effectiveness of antibiotics against drug-resistant bacteria

For the first time, unleashing the power of antimicrobial peptides

Amferia wound dressing launched in eight European countries by Orkla

How this platform technology can revolutionise treatments

Wound Care

Pre-surgery

Antimicrobial sprays

Antibacterial coatings

Amferia’s general patent now granted in Europe, the U.S. and China

Launching our first product for veterinary use

Addressing antibiotic resistance the sustainable way

After years of research, we suddenly realised how to combine our findings. It was a eureka moment.

New Study finds Amferia's Peptide-Hydrogel restores the effectiveness of antibiotics against drug-resistant bacteria

How this platform technology
can revolutionise treatments

After years of research, we suddenly realised how to combine our findings.
It was a eureka moment.